Medicinal Genomics

FEBRUARY 8, 2024

Employees in cannabis production facilities are exposed to large quantities of ground product, which may trigger asthma, allergic rhinitis, and urticaria. In November 2023, the CDC reported a fatal occupational asthma attack suffered by an employee at a Massachusetts cannabis production facility. This piqued our interest.

Treatment 98

Treatment Dispensary Safety Cannabis 98

Project CBD

OCTOBER 26, 2023

Adapted from The Cannabis Cancer Connection: How to use cannabis and hemp to kill cancer cells by Joe D. Goldstrich, MD, with Angela Bacca (Flower Valley Press, 2023). I advise my patients to stop using cannabis for 36 to 48 hours prior to chemotherapy and to start again 36 to 48 hours after their session.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

AUGUST 10, 2022

Petition: Reschedule psilocybin for medical research on untreatable conditions. Antidepressant use in England has doubled over the last decade and 1 in every 10 pounds spent by the NHS is for mental health treatments. Deadline 3 February 2023 All petitions run for 6 months. Share this petition. Created by Ros Stone.

Conditions 52

Conditions Research and Development Treatment 52

Project CBD

MAY 24, 2023

Ten years ago, most cannabis consumers couldn’t tell a terpene from a cannabinoid. Cannabis flower is categorized according to terpene profile. 1 Now it turns out that some terpenes also may contribute to the cannabis high. Is this evidence of the fabled cannabis entourage effect? But today things are different.

Terpenes 274

Terpenes THC Cannabinoids Concentrates 274

Veriheal

MARCH 2, 2024

When it comes to cannabis in Japan, the country is known for maintaining strict prohibition and regulation of cannabis-derived products. The revised legislation would permit clinical use and production of cannabis for medical CBD products, like Epidiolex , that have been approved in the U.S.

Legalization 105

Legalization Epilepsy Clinical Trials THC 105

Veriheal

JANUARY 26, 2024

In April 2023, Delaware became the 22nd state to legalize recreational cannabis with the passing of HB 1 and HB 2. In the meantime, Delaware has been making some serious moves to expand its medical cannabis industry ahead of adult-use sales, which may not begin for another year or more.

Access 105

Access Legalization Marijuana Dispensary 105

Illinois News Joint

APRIL 27, 2024

The Academic Cannabis Conference , produced by News Joint Events , is pleased to announce its full presenter lineup and schedule. Professors and professionals in the cannabis field will deliver research and educational presentations from 12:30-4:20 p.m. at the Garden Grove Event Center in Carbondale on May 4. 1:00 p.m. – 3:30 p.m. –

Research and Development 92

Research and Development Events Environment Education 92

Dykema (Cannabis Law Blog)

APRIL 20, 2023

The state of Texas has a long history of regulating cannabis use. Since 1915, when the first city ordinance was passed banning cannabis in El Paso, [i] the legal landscape in Texas and the rest of the country continues to evolve at different rates. Specifically, H.B.

Law 74

Law Chronic Pain Conditions Medicine 74

Veriheal

JANUARY 16, 2024

As the natural remedy of cannabis gains more widespread acceptance and products become increasingly available, its healing properties are slowly gaining acceptance into mainstream culture. Treatment plans are customized to each individual’s needs.

Patients 113

Patients CBD Treatment Research and Development 113

MMJ Recs

MAY 29, 2024

This program allows individuals with qualifying medical conditions to access marijuana for therapeutic purposes upon obtaining a medical marijuana card. The importance of access to medical marijuana for individuals with qualifying medical conditions cannot be overstated. These conditions have been outlined above.

Marijuana 52

Marijuana Programs Patients Conditions 52

CannaMD

JULY 11, 2023

An exhaustive study by the American Medical Association (AMA) has confirmed what current medical marijuana patients have stated for quite some time — that medical cannabis treatment improves health-related quality of life for patients with a range of health conditions.

Marijuana 52

Marijuana Conditions Patients Treatment 52

Veriheal

SEPTEMBER 15, 2023

All eyes are on Georgia’s medical cannabis program as it continues to grow. a prominent cannabis corporation in the state. Trulieve plans to open a new medical cannabis dispensary in Evans, Georgia. The History of the Georgia Medical Cannabis Program Georgia’s medical cannabis program started sales this past spring.

Programs 62

Programs Legalization Oil Conditions 62

Cannabis Law Report

APRIL 19, 2023

Here’s the blurb With research showing that psychedelics hold substantial promise for the treatment of mental health conditions such as depression, PTSD and addiction, PSYCH Symposium provides a platform for decision makers to accelerate the development and delivery of these medicines.

Research and Development 52

Research and Development Events Treatment Policy 52

Veriheal

JUNE 22, 2023

Background of the Case The case involved a 21-year-old defendant facing a DUI charge in early 2023. The judge responded by stating that anxiety was not a sufficient reason to use medical marijuana and ordered the defendant to stop using cannabis medicinally as part of her probation.

Patients 75

Patients Treatment Conditions Cannabis 75

Veriheal

DECEMBER 14, 2023

There is a persistent and common belief throughout society that using cannabis over an extended period of time (or, in some cases, even once) can lead to a decline in mental abilities and function. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Canna Law Blog

MARCH 11, 2024

In November 2012, Washington voters approved the production, processing, and retail sales of recreational cannabis within Washington state under what is known as Initiative 502 (“I-502”). Cannabis sales in Washington state are currently taxed at a rate of 37%, in addition to the general state and local sales and use taxes.

Chronic Pain 104

Chronic Pain Recreational Patients Medicine 104

Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. And it’s not just ringing.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Veriheal

NOVEMBER 7, 2023

Ohio voters will get the chance to vote on recreational cannabis legalization this November. states and Washington DC with recreational cannabis. ounces of cannabis and 15 grams of concentrates. ounces of cannabis and 15 grams of concentrates. All retail cannabis sales will come with a 10% tax.

Legalization 120

Legalization Legislation Programs Recreational 120

Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Veriheal

MAY 30, 2023

But what if a safe and effective complementary plant-based treatment was widely available to alleviate cancer pain? A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. According to a 2016 study , about 39.3%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

JUNE 27, 2023

Source: Psychiatrist.com Today we published a new draft guidance to highlight fundamental considerations to researchers investigating the use of psychedelic drugs for treatment of medical conditions, including psychiatric or substance use disorders. link] pic.twitter.com/8hihHqLJ6j — U.S.

Treatment 52

Treatment Conditions 52

Cannabis Law Report

JULY 13, 2022

The table below sets out the TGA’s priority areas for compliance activities relating to the import, advertising and supply requirements of the Therapeutic Goods Act 1989 from 1 July 2022 to 30 June 2023. Ensure compliance with the requirements of the Therapeutic Goods Act 1989 across the medicinal cannabis industry.

Compliance 52

Compliance Compliance Wellness and Beauty Vaping 52

Veriheal

APRIL 1, 2024

Cannabis is not legal in North Carolina for medicinal or recreational purposes yet, but one group has their own rules–the Eastern Band of Cherokee Indians (EBCI). Officially dubbed the Great Smoky Cannabis Company, this dispensary is opening in a former bingo hall near the Harrah’s Cherokee Casino Company.

Dispensary 106

Dispensary Chronic Pain Medicine History 106

Illinois News Joint

FEBRUARY 8, 2023

Every year, we at Illinois News Joint purposely try to expand on several aspects of our coverage, and in 2023, we have decided to direct more attention toward advocating for the needs, rights, and betterment of medical cannabis cardholders in Illinois. We work with patients of all ages with a wide variety of conditions.

Patients 84

Patients Treatment Environment Conditions 84

Cannabis Law Report

FEBRUARY 14, 2023

Davis (Melbourne) and Alex Tzanidis (Melbourne) Davies Collison Cave In a decision released on 3 February 2023, the Australian Therapeutic Goods Administration (TGA) have agreed to amend the Poisons Standard to include new Schedule 8 entries for both psilocybine (i.e., Following this change, which is […]

Legalization 52

Legalization Treatment Conditions 52

Project CBD

SEPTEMBER 12, 2023

But the quality of the government-issue reefer matters less than the fact that Uncle Sam has been supplying him with it regularly since 1982, when Rosenfeld won the right to smoke cannabis for reasons of medical necessity under the auspices of the federal government’s Compassionate Investigational New Drug (IND) program.

Chronic Pain 228

Chronic Pain Treatment Cannabinoids Research and Development 228

Veriheal

JUNE 20, 2023

Depression and addiction continue to impact millions of lives worldwide, making the search for effective treatments crucial. In a recent 2023 study , scientists have developed two promising drug candidates for treating these conditions, drawing inspiration from a traditional African psychedelic plant medicine called ibogaine.

Medicine 98

Medicine Research and Development Treatment Conditions 98

The Cannigma

JULY 5, 2022

Cannabis regulation in Georgia is complicated, but the plant is still illegal. The program was legalized in 2015 and patients with qualifying conditions can get a prescription for up to 20oz of low THC oil, capsules, patches, or lotion. Several cities have decriminalized cannabis possession, but this is not statewide.

Law 96

Law Decriminalization Programs Patients 96

MMJ Recs

JANUARY 20, 2024

Let’s take a closer look at medical marijuana laws in Maryland and how they affect those in need of MMJ treatment! The state’s thoughtful approach seeks to ensure that those with genuine medical needs have access to this alternative treatment while maintaining a balance between patient care and preventing misuse.

Law 52

Law Marijuana Patients Chronic Pain 52

Veriheal

AUGUST 21, 2023

On June 22, 2023, Mets owner Steve Cohen and his wife made headlines with his remarkable donation of $5 million donated to the Multidisciplinary Association for Psychedelic Studies (MAPS). If the FDA approves the application, it will pave the way for integrating psychedelic treatment into mainstream medical health care.

Therapy 90

Therapy Research and Development Treatment Environment 90

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. Patients may want to seek assistance from a certified professional prior to embarking on treatment.

Therapy 78

Therapy Access Blood Pressure Treatment 78

Nature's Way Medicine

FEBRUARY 19, 2021

This week’s cannabis news consists of updates for Mississippi, Wisconsin, North Dakota, Michigan, and Pennsylvania. President Biden’s administration does not seem to want to relax their stance on cannabis but U.S. cannabis jobs are at an all time high. US Cannabis Jobs at 321,000. North Dakota.

Patients 97

Patients Dispensary Conditions Cannabis 97

Veriheal

NOVEMBER 28, 2023

However, a recent 2023 study published in JAMA Psychiatry raises serious questions about the accuracy of these tests when it comes to detecting impairment induced by tetrahydrocannabinol (THC). The current reliance on FSTs to assess cannabis-induced impairment in the U.S. poses a challenge. One significant case, Commonwealth v.

THC 113

THC Safety Treatment Legalization 113

MMJ Recs

DECEMBER 13, 2023

While the state has traditionally held a conservative stance on cannabis, there has been a gradual shift in public opinion and legislative action, paving the way for a more inclusive and patient-centric approach to healthcare. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Cannabis Law Report

OCTOBER 6, 2021

Two lawmakers from South Florida have announced that they are making a new push to study psychedelic drugs like magic mushrooms and ketamine in clinical settings to treat conditions like PTSD and depression. 2023, comparing psychedelic therapy to traditional treatments already in use. Representative Michael Grieco. Definitely.

Legislation 52

Legislation Research and Development Treatment Therapy 52

Cannabis Law Report

MARCH 19, 2022

Patients and clinicians are increasingly optimistic about the efficacy of psychedelic drugs as an alternative or supplement to traditionally manufactured pharmaceuticals to treat depression, anxiety, addiction, PTSD, anger and aggression, and other psychological conditions.

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Veriheal

FEBRUARY 17, 2023

Kentucky does not currently offer medical marijuana cards or have an active medical cannabis program. What Kentucky has is a smokescreen of confusion brought on by lawmakers that don’t support the will of the public to legalize cannabis. 1, 2023, Gov. You can then bring that cannabis back into the state with you.

Marijuana 84

Marijuana Conditions Legalization Treatment 84